Gutenberg Open Science: Any progress in informed consenting for cancer treatment? : Results from a cross sectional analysis at a comprehensive cancer center

Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7556

Full metadata record

DC Field	Value	Language
dc.contributor.author	Schwaegermann, Marie-Kristin	-
dc.contributor.author	Schranz, Melanie	-
dc.contributor.author	Moehler, Markus	-
dc.contributor.author	Labenz, Christian	-
dc.contributor.author	Moringlane, Alice	-
dc.contributor.author	Schmidt, Marcus	-
dc.contributor.author	Theobald, Matthias	-
dc.contributor.author	Hess, Georg	-
dc.date.accessioned	2022-08-16T10:12:32Z	-
dc.date.available	2022-08-16T10:12:32Z	-
dc.date.issued	2021	-
dc.identifier.uri	https://openscience.ub.uni-mainz.de/handle/20.500.12030/7570	-
dc.description.abstract	Purpose Informed consent is required prior to any medical procedure. In the context of cancer treatment, special efforts are needed to inform cancer patients properly about treatment, potential sequelae and alternative therapies. Little is known about the effectiveness of current informed consent strategies and patients’ individual satisfaction. Given the heterogeneity in terms of age, education, sex and other factors, detailed understanding of patients’ comprehension and perception is the basis for further optimization of the informed consent process, which was the aim of the current investigation. Methods Patients with a new cancer diagnosis and recent informed consent were asked to complete a questionnaire about satisfaction, comprehension, time management, physician–patient relationship and other items of the informed consent process. Patients were followed for 6 months and invited to complete a follow-up questionnaire. Results In total, 89 patients completed the first questionnaire and 52 the follow-up questionnaire. Subjective understanding was assumed high, however, this did not correlate with objective understanding. Age and education were identified as influencing factors for comprehension. 85% of the patients were satisfied with the information provided. A major gap was the information on alternative therapies. Moreover, not all patients perceived the consent dialog as such, and particularly the individual treatment intention partially remained unclear for some patients. Conclusions To ensure that informed consent is based on solid understanding, informed consenting must be patient-centered and consider the individual expectations, needs and abilities of cancer patients. Further studies are required to develop tailored informed consent strategies.	en_GB
dc.language.iso	eng	de
dc.rights	CC BY	*
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/	*
dc.subject.ddc	610 Medizin	de_DE
dc.subject.ddc	610 Medical sciences	en_GB
dc.title	Any progress in informed consenting for cancer treatment? : Results from a cross sectional analysis at a comprehensive cancer center	en_GB
dc.type	Zeitschriftenaufsatz	de
dc.identifier.doi	http://doi.org/10.25358/openscience-7556	-
jgu.type.dinitype	article	en_GB
jgu.type.version	Published version	de
jgu.type.resource	Text	de
jgu.organisation.department	FB 04 Medizin	de
jgu.organisation.number	2700	-
jgu.organisation.name	Johannes Gutenberg-Universität Mainz	-
jgu.rights.accessrights	openAccess	-
jgu.journal.title	Journal of cancer research and clinical oncology	de
jgu.journal.volume	147	de
jgu.pages.start	2117	de
jgu.pages.end	2126	de
jgu.publisher.year	2021	-
jgu.publisher.name	Springer	de
jgu.publisher.place	Berlin u.a.	de
jgu.publisher.issn	1432-1335	de
jgu.organisation.place	Mainz	-
jgu.subject.ddccode	610	de
jgu.publisher.doi	10.1007/s00432-020-03495-1	de
jgu.organisation.ror	https://ror.org/023b0x485	-
Appears in collections:	JGU-Publikationen

Files in This Item:

	File	Description	Size	Format
	any_progress_in_informed_cons-20220812155755800.pdf		862.89 kB	Adobe PDF	View/Open

Show simple item record